36 ApoB also includes the contribution of very‐low‐density lipoproteins, which may be significant in patients with mixed dyslipidemia.
← all excerpts
Changes in lipoprotein particle number with ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidemic patients.
1
—
—